Related Experiment Video
Updated: Jul 13, 2026

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
Published on: December 18, 2012
Potential prophylactic and therapeutic vaccines for HSV infections
Srividya Ramachandran1, Paul R Kinchington
1Graduate Program in Molecular Virology and Microbiology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Abstract:
The human herpesviruses herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) can cause severe recurrent disease in humans and establish lifelong infection in their hosts. Several antiviral therapies are available to control disease and spread, but these are not completely effective and do not affect latent virus. The need for vaccines for HSV is urgent, both for controlling initial infection and spread of disease as well as to limit recurrences. Several approaches including subunit vaccines, peptide vaccines, live virus vectors and DNA vaccine technology have been used in developing both prophylactic and therapeutic vaccines for HSV and these are reviewed here.
Related Concept Videos
Herpes
Genital Herpes
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Respiratory Syncytial Virus Disease
Vaccines
Vaccinations

